% | $
Quotes you view appear here for quick access.

Tibet Pharmaceuticals, Inc. Message Board

  • unclefulbert unclefulbert May 10, 2012 9:22 AM Flag

    Good news from a Chinese stock with PE of 2

    Yongye International, Inc. (YONG)

    3.23 May 9, 3:59PM EDT|Pre-Market: 3.52 Up 0.29 (8.98%) 9:20AM EDT - Nasdaq Real Time Price

    First Quarter 2012 Financial Highlights

    Revenue increased 28.2% to $64.4 million from $50.2 million in the first quarter of 2011
    Gross profit increased 29.7% year-over-year to $35.4 million
    Income from operations was $21.9 million, an increase of 94.1% over income from operations of $11.3 million in the first quarter of 2011
    Net income attributable to Yongye increased 95.8% to $16.4 million, or $0.27 per diluted share, from $8.4 million, or $0.16 per diluted share, in the same period of 2011
    Adjusted net income attributable to Yongye, which excludes non-cash expenses related to share-based compensation for management and independent directors, the amortization of the acquired Hebei customer list, and a change in the fair value of derivative liabilities, was $18.3 million, or $0.31 per diluted share, compared to a net income of $13.3 million, or $0.27 per diluted share, in the same period of 2011*
    Operating cash flow was $61.7 million compared to $6.6 million in the same period of 2011

    Mr. Zishen Wu, Chairman and Chief Executive Officer of Yongye International, stated, "We are pleased to announce strong first quarter results with year-over-year increases in revenue and net income of 28.2% and 95.8%, respectively. The strong growth demonstrates the continued strength of our brand and our successful launch of two new products, which contributed 77.3% of our total liquid crop nutrient sales this quarter. These new products highlight our commitment to product diversification and our strong research capabilities; we believe they will further solidify our market leading position.

    SortNewest  |  Oldest  |  Most Replied Expand all replies